Company Filing History:
13 out of 39 
2 out of 2 Years Active: 1997-2005
Title: The Innovative Contributions of Ernest R. Pariser
Introduction
Ernest R. Pariser is a prominent inventor based in Belmont, MA, known for his significant contributions to the field of biopolymers and polysaccharides. With a remarkable portfolio of 15 patents, Pariser has dedicated his career to the development of innovative biocompatible materials, paving the way for advancements in pharmaceuticals and biotechnology.
Latest Patents
Among his latest innovations are two notable patents related to poly-β-1→4-N-acetylglucosamine (p-GlcNAc). The first patent focuses on a purified and easily produced form of p-GlcNAc, which is characterized as a high molecular weight polysaccharide. This unique polymer is composed of monosaccharide sugars linked in a β-1→4 conformation and is free from proteins and contaminants. The invention also outlines methods for the purification of p-GlcNAc from microalgae, particularly diatom sources, and describes its potential derivatives and reformulations.
The second patent similarly addresses pharmaceutical compositions containing p-GlcNAc, detailing its uses in pure and reformulated forms. Both patents exemplify Pariser’s commitment to enhancing the applications of biocompatible materials in the medical field.
Career Highlights
Throughout his career, Pariser has been associated with Marine Polymer Technologies, Inc., where he contributed his expertise to the development of innovative products based on biopolymer science. His work in the industry has established him as a key figure in the advancement and commercialization of biocompatible materials.
Collaborations
Pariser has collaborated with esteemed colleagues, including John N. Vournakis and Sergio Finkielsztein. Together, they have contributed to the growth of knowledge in biopolymer research and development, further enriching the field with their collective expertise.
Conclusion
Ernest R. Pariser’s dedication to innovation in biocompatible polysaccharides has solidified his reputation as a leading inventor. With a strong portfolio of patents and collaborations, he continues to impact the fields of pharmaceuticals and biotechnology, driving important advancements that benefit both science and society.